Suppression subtractive hybridization (SSH) was used to isolate genes that
were differentially expressed in anaplastic lymphoma kinase (ALK)-positive
and ALK-negative anaplastic large cell lymphoma. In addition, this approach
was applied to Hodgkin's disease cases with different clinical outcomes. S
SH combines a normalization step that equalizes the abundance of cDNAs with
in the sequences to be tested and a subtraction step that excludes the comm
on sequences between the target and the control. In a model system, the SSH
technique enriches for rare sequences up to 5,000-fold in one round. We ha
ve isolated several genes whose expression varied significantly with regard
to the tumour subtypes. There were different genes with known or unknown f
unctions. We aim to compare the results of the SSH approach with those obta
ined with high density filters. In a near future, we would like to design D
NA chips specific of each pathology that could be used for clinical purpose
s (evaluation of prognosis and therapeutic response).